Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Peter J. Duggan

3 papers in the library · 6 citations · publishing 2023-2024

Papers

Introduction to the chemistry and pharmacology of psychedelic drugs

Australian Journal of Chemistry July 4, 2023 Scott R. Walker, Glenn A. Pullella, Matthew Piggott et al. 5 citations

Psychedelic science is a multi-disciplinary field that has recently gained public attention due to high-profile studies on psychedelic-assisted therapy for difficult-to-treat mental health conditions. This Primer Review provides an overview of the chemistry and pharmacology of psychedelics, covering natural, semi-synthetic, and fully synthetic substances. It begins with a summary of important psychedelic classes and their traditional human use dating back to prehistoric times. The review examines ergolines (e.g., LSD), tryptamines (e.g., psilocybin, DMT), phenethylamines (e.g., mescaline, MDMA), arylcyclohexylamines (e.g., ketamine, PCP), and other naturally occurring drugs like muscimol and salvinorin A. Contributions from pioneers Albert Hofmann and Alexander Shulgin are briefly summarized, with references to primary literature.

Could the medicalization of psychedelics lead to the next generation of antidepressants?

The Biochemist March 28, 2024 Peter J. Duggan, S. Walker 1 citation

Humans have used hallucinogenic substances since prehistoric times, often in religious rituals. In the 1960s, the counterculture centered on psychedelics like LSD, leading to their worldwide prohibition under the 1971 UN Convention on Psychotropic Substances, which limited scientific research. Recently, hints that psychedelics may help treat resistant depression and PTSD have spurred efforts to gather clinical data for potential regulatory approval as medical treatments.